Avacta denies press speculation over potential fundraising
(Sharecast News) - Oncology drug developer Avacta Group responded to recent market speculation over a potential fundraising initiative on Monday.
Read moreWed, 10th Oct 2018 16:33
(Sharecast News) - Oncology drug developer Avacta Group responded to recent market speculation over a potential fundraising initiative on Monday.
Read more(Alliance News) - Stock prices in London opened lower on Monday, ahead of more interest rate decisions, and amid fears for China's slowing economic recovery.
Read more(Alliance News) - Stocks in London are called lower on Monday, ahead of more central bank decisions, while a meeting between US Secretary of State Antony Blinken and his Chinese counterpart put relations between the two nations back under the spotlight.
Read more(Sharecast News) - Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics.
Read more(Alliance News) - Avacta Group PLC on Monday celebrated "rapid" progress on its joint venture in South Korea, following a second equity payment.
Read more(Sharecast News) - Life science company Avacta Group announced the acquisition of Coris Bioconcept for initial cash consideration of £7.4m on Thursday.
Read more(Alliance News) - Avacta Group PLC on Thursday said that it has bought Coris Bioconcept SRL, adding a range of professional-use rapid tests to its product portfolio.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Sharecast News) - Oncology and diagnostics developer Avacta announced the dosing of the first patient in the United States under its investigational new drug (IND) application on Thursday - a milestone for its first therapeutic product 'AVA6000', based on its proprietary 'preCISION' technology.
Read more(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Sharecast News) - Oncology-focussed drugs and diagnostics developer Avacta reported full-year revenue of £9.7m in its preliminary results on Tuesday, up from £2.9m year-on-year.
Read moreWednesday 19 April | |
Antofagasta PLC | Trading Statement |
discoverIE Group PLC | Trading Statement |
Distribution Finance Capital Holdings PLC | Full Year Results |
Hunting PLC | Trading Statement |
Just Eat Takeaway.com NV | Trading Statement |
Kainos Group PLC | Trading Statement |
Liontrust Asset Management PLC | Trading Statement |
M Winkworth PLC | Full Year Results |
Network International Holdings PLC | Trading Statement |
Thursday 20 April | |
AJ Bell PLC | Trading Statement |
Arix Bioscience PLC | Full Year Results |
Centamin PLC | Trading Statement |
Deliveroo PLC | Trading Statement |
Dianomi PLC | Full Year Results |
Dunelm Group PLC | Q3 Results |
Foxtons Group PLC | Trading Statement |
GB Group PLC | Trading Statement |
Hochschild Mining PLC | Full Year Results |
Intelligent Ultrasound Group PLC | Full Year Results |
Oxford BioMedica PLC | Full Year Results |
PensionBee Group PLC | Trading Statement |
Rentokil Initial PLC | Trading Statement |
Rio Tinto PLC | Trading Statement |
Senior PLC | Trading Statement |
Segro PLC | Trading Statement |
WH Smith PLC | Half Year Results |
Friday 21 April | |
Angle PLC | Full Year Results |
BHP Group Ltd | Trading Statement |
Lookers PLC | Full Year Results |
Monday 24 April | |
Brighton Pier Group PLC | Full Year Results |
CentralNic Group PLC | Trading Statement |
Checkit PLC | Full Year Results |
Egdon Resources PLC | Half Year Results |
Keystone Law Group PLC | Full Year Results |
Lok'n Store Group PLC | Half Year Results |
Novacyt SA | Full Year Results |
Tuesday 25 April | |
AB Dynamics PLC | Half Year Results |
Anglo American PLC | Trading Statement |
Associated British Foods PLC | Half Year Results |
Avacta Group PLC | Full Year Results |
Banco Santander SA | Q1 Results |
Card Factory PLC | Full Year Results |
Coca-Cola Europacific Partners PLC | Trading Statement |
Corero Network Security PLC | Full Year Results |
Dillistone Group PLC | Full Year Results |
Focusrite PLC | Half Year Results |
IWG PLC | Trading Statement |
Jadestone Energy PLC | Full Year Results |
Next Fifteen Communications Group PLC | Full Year Results |
Northcoders Group PLC | Full Year Results |
Petrofac Ltd | Full Year Results |
Quilter PLC | Trading Statement |
Resolute Mining Ltd | Trading Statement |
RWS Holdings PLC | Trading Statement |
Travis Perkins PLC | Trading Statement |
WAG Payment Solutions PLC | Trading Statement |
Whitbread PLC | Full Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Sharecast News) - Life science company Avacta Group announced the presentation of pre-clinical data for its novel 'preCISION' proteasome inhibitor AVA3996 on Monday.
Read more(Alliance News) - Avacta Group PLC on Thursday said it opened its first two clinical investigator sites for the phase 1 clinical trial of AVA6000 on Wednesday, under it US investigational new drug application.
Read more(Sharecast News) - Life sciences company Avacta has opened its first two clinical investigator sites in the US for a Phase 1 clinical study on its AVA6000 candidate.
Read more